ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 80 filers reported holding ACLARIS THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $678,678 | -44.0% | 83,891 | +24.7% | 0.35% | +26.4% |
| Q3 2021 | $1,211,000 | -42.2% | 67,300 | -43.6% | 0.28% | -52.1% |
| Q2 2021 | $2,096,000 | -81.7% | 119,378 | -73.8% | 0.58% | -80.7% |
| Q1 2021 | $11,476,000 | +57.4% | 455,385 | -59.6% | 2.99% | +13.8% |
| Q4 2020 | $7,290,000 | +98.0% | 1,126,675 | -21.4% | 2.63% | +141.4% |
| Q3 2020 | $3,682,000 | +31.5% | 1,432,817 | -17.1% | 1.09% | +607.1% |
| Q2 2020 | $2,801,000 | +2.8% | 1,728,787 | -34.0% | 0.15% | -87.5% |
| Q1 2020 | $2,724,000 | -31.5% | 2,619,187 | +7.7% | 1.23% | -1.6% |
| Q4 2019 | $3,978,000 | +108.2% | 2,431,269 | +37.4% | 1.25% | +82.8% |
| Q3 2019 | $1,911,000 | -46.4% | 1,769,785 | +8.6% | 0.69% | -51.2% |
| Q2 2019 | $3,568,000 | +9.1% | 1,629,327 | +198.6% | 1.41% | +8.9% |
| Q1 2019 | $3,269,000 | – | 545,729 | – | 1.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Endurant Capital Management LP | 1,769,785 | $1,911,000 | 0.69% |
| Telemetry Investments, L.L.C. | 214,593 | $232,000 | 0.67% |
| Aisling Capital Management LP | 634,455 | $685,000 | 0.36% |
| Broadfin Capital, LLC | 1,620,000 | $1,750,000 | 0.32% |
| MFN Partners Management, LP | 1,500,000 | $1,620,000 | 0.24% |
| Sofinnova Investments, Inc. | 1,911,573 | $2,064,000 | 0.19% |
| Rock Springs Capital Management LP | 2,974,754 | $3,213,000 | 0.13% |
| Alambic Investment Management, L.P. | 150,636 | $163,000 | 0.12% |
| Cormorant Asset Management, LP | 250,000 | $270,000 | 0.02% |
| Man Group plc | 3,734,793 | $4,034,000 | 0.02% |